Astrazeneca Ab & Anr. v. Westcoast Pharmaceutical Works Limited

182933814

Astrazeneca filed suit against Westcoast Pharmaceutical Works Limited alleging infringement of its patent (IN 297581) covering the cancer drug Osimertinib. The plaintiffs sought permanent injunctions and damages, asserting that the defendant's offer to contractually manufacture and sell the patented compound constituted infringement. Despite initial defenses by the defendant regarding regulatory approval issues, the court found that due to the defendant's failure to file a written statement within the statutory period, the suit was decreed in favor of AstraZeneca, granting them relief and substantial costs.

Jurisdiction
India
Court
Delhi High Court
Case Number
182933814
Decision Date
12 November 2024

Detailed Summary

Astrazeneca filed suit against Westcoast Pharmaceutical Works Limited alleging infringement of its patent (IN 297581) covering the cancer drug Osimertinib. The plaintiffs sought permanent injunctions and damages, asserting that the defendant's offer to contractually manufacture and sell the patented compound constituted infringement. Despite initial defenses by the defendant regarding regulatory approval issues, the court found that due to the defendant's failure to file a written statement within the statutory period, the suit was decreed in favor of AstraZeneca, granting them relief and substantial costs.

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court. Understanding the court's reasoning in Astrazeneca Ab & Anr. vs Westcoast Pharmaceutical Works Limited is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentP57302274

Deepak Nitrite LimitedvsThe Assistant Controller General of Patents and Designs

The Bombay High Court set aside an order of the Assistant Controller of Patents and Designs refusing a patent application for a free-flowing food-grade sodium nitrite and its production method. The court held that the impugned order lacked adequate reasoning and analysis of the rival submissions. The patent application is to be decided afresh within 12 weeks. The court emphasized the importance of passing well-reasoned and speaking orders in patent cases.

patent155791263

Ctr Manufacturing Industries Pvt. Ltd.vsTri Parulex Fire Protection System & Ors.

The Plaintiff filed an interim application seeking an injunction against the Defendants for allegedly infringing Patent No.202302, which covers a specific operational sequence involving differential relay, Buchholz relay, and circuit breaker in fire prevention systems (NIFPS). The court accepted an undertaking from the Defendants not to use this specific patented sequence but directed both parties to file affidavits addressing the technical scope of the patent.

patent49446853

Commonwealth Scientific and Industrial Research OrganizationvsThe Assistant Controller of Patents and Designs, The Patent Office

The appellant challenged an order rejecting its patent application (No. 2072/CHENP/2011) because the current set of amended claims were deemed beyond the scope of Section 59 of the Patents Act, 1970. The court examined whether the amendments expanded or narrowed the original claim scope and found that the specificity incorporated in the amended claims curtailed rather than expanded the original scope.

patent52110671

Quikr India Private LimitedvsSellquikr Private Limited

The Karnataka High Court disposed of the writ petition based on a joint compromise memo between Quikr India Private Limited and Sellquikr Private Limited. The core agreement stipulated that Sellquikr acknowledged having no rights over Quikr's registered trademarks and copyrighted material. Furthermore, Sellquikr committed to immediately changing its corporate name by removing 'QUIKR,' taking down all associated websites and applications, transferring the domain name sellquikr.in/ to Quikr, and ceasing any use of Quikr's intellectual property.

patent142894513

Vgx Pharmaceuticals IncvsThe Controller General Of Patents, Designs And Trademarks

Vgx Pharmaceuticals Inc challenged the refusal of its patent application concerning 'Electroporation Devices and Methods.' The appeal argued that the Assistant Controller's order was unreasoned, failing to provide a clear justification for rejecting the invention based on prior art D4 and D5. The Delhi High Court agreed, finding the impugned order cryptic and lacking necessary analysis regarding inventive step. Consequently, the court allowed the appeal, setting aside the refusal and remanding the matter back to the Patent Office for fresh consideration.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call